# Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/chemotherapy-refractory-diffuse-large-b-cell-lymphoma-and-indolent-b-cell/

## Facts

| Field | Value |
| --- | --- |
| Author Names | James N. Kochenderfer,Mark E. Dudley,Sadik H. Kassim,Robert Somerville,Robert O. Carpenter,Maryalice Stetler‐Stevenson,James C. Yang,Giao Q. Phan,Marybeth S. Hughes,Richard M. Sherry,Mark Raffeld,Steven A. Feldman,Lily Lu,Yong F. Li,Lien T. Ngo,André Goy,Tatyana Feldman,David Spaner,Michael Wang,Clara C. Chen,Sarah M. Kranick,Avindra Nath,Debbie-Ann N. Nathan,Kathleen E. Morton,Mary Ann Toomey,Steven A. Rosenberg |
| Citations | 1,612 |
| DOI | 10.1200/jco.2014.56.2025 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2014.56.2025?role=tab |
| OpenAlex ID | https://openalex.org/W2170513194 |
| PMID | 25154820 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Mark Raffeld](https://scholariq.org/researchers/mark-raffeld/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.